It has to be kept in mind that cerebral metastases occur usually in the final stage of the metastasizing process. Therefore, in general the survival time will be limited. Several prognostic factors have been defined, which mainly influence the survival time of the patients: -the extent of extracerebral metastases, -the number of cerebral lesions, -the time interval between the occurrence of the primary tumor and the development of cerebral metastases, -the Karnofsky performance score, and -the age of the patient [1] . The indication for surgery is based on these prognostic factors. Surgery is indicated in patients with a solitary brain metastasis, which means that the primary tumor is under control and the patient is free of extracerebral metastasis. Whenever the cerebral lesion is accessible, surgery should be performed [2, 3] . In these cases even long-term survivors can be expected (more than 10 years). However, the size, the location, and the histology of the metastasis will determine the decision pro and contra surgery. For instance: Small-cell lung cancer is known to be very radioand chemosensitive. In these cases radio-or chemotherapy will be adequate. These lesions should not be operated on, with the exception of very big tumors, which have led to lifethreatening increase in brain pressure. Also lesions with a diameter of 1 cm or less or metastases localized in the brain stem or basal ganglia are favorably treated by radiosurgery. In all other cases we prefer surgery whenever the patient is in good clinical condition and under the age of 70 (up to maximally 75) years. In singular cerebral metastasis the extent of the extracerebral seeding, the control of the primary tumor, the Karnofsky performance score, and the age of the patient will determine the decision pro or contra operation. Stable disease, a Karnofsky score of more than 70, and age under 70 years will favor surgery. Numerous retrospective studies [2, 3] could demonMetastases to the brain occur in 20-30% of patients with systemic cancer. Depending on the primary tumor the frequency is even higher. In autopsy studies of patients with metastasizing malignant melanomas the occurrence of cerebral lesions ranges between 40 and 75%. Most brain metastases, however, generate from primary lung and breast carcinomas. The brain metastasis threatens the life of the patient by increasing the intracranial pressure or by seeding in functionally important brain areas. Neurosurgical techniques have improved tremendously during the last two decades. One of the main advances was the development of neuronavigational devices. Neuronavigation is a computer-aided method that enables us to fuse 3D-images ('virtual world'), obtained preoperatively, with the physical world of the intraoperative situation. By this method it is possible to target deep-seated or multiple lesions by pre-and intraoperative computed imaging and by choosing the operative approach so as to avoid additional iatrogenic neurological deficits. The further important progress is the intraoperative identification of functionally important areas of the brain, e.g. the motor cortex and the speech area by electrophysiological monitoring, called 'brain mapping'. Intraoperatively, the motor cortex can be defined by somato-sensory evoked potentials. The phase reversal of N20 is specific for the central sulcus. This method can be applied on a routine basis. Brain mapping of the speech area has to be performed on awake patients. Therefore, speech monitoring is only applied in specialized centers and, in general, is not necessary in patients with metastasis. The advances in neurosurgical techniques have led to a new understanding in surgery of metastasis. The fact that cerebral lesions -even small and deep-situated ones -can be approached in a reliable and safe manner, makes surgery a valuable alternative in metastasis treatment. The question arises, when is it reasonable to perform surgery in cerebral metastases and when should other methods be preferred?
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Conclusion
Surgery should be considered whenever possible. This means that the patient has to be in good clinical condition (Karnofsky performance score > 70), the extracerebral metastases should be stable, the number of cerebral lesions should not exceed more than 3 seedings, and the age of the patient should be below 70 years. Since brain metastases are usually well circumscribed, complete extirpation seems to be possible. Postoperative MRI should be demanded in order to confirm complete extirpation. Additional radiotherapy is indicated in case of subtotal resection of a single lesion and in multiple lesions. In single brain metastasis a prospective randomized trial is necessary to prove whether conventional radiotherapy is essential after surgery in the primary treatment of the tumors or can be delayed until cerebral lesions recur. Radiosurgery is an alternative to surgery in the treatment of metastasis. 
